Surmodics - 22 Year Stock Price History | SRDX

Historical daily share price chart and data for Surmodics since 1998 adjusted for splits. The latest closing stock price for Surmodics as of August 12, 2020 is 47.36.
  • The all-time high Surmodics stock closing price was 80.35 on September 13, 2018.
  • The Surmodics 52-week high stock price is 49.00, which is 3.5% above the current share price.
  • The Surmodics 52-week low stock price is 22.06, which is 53.4% below the current share price.
  • The average Surmodics stock price for the last 52 weeks is 40.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Surmodics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 38.6505 40.9600 48.7200 22.4600 47.3600 14.31%
2019 44.6504 46.4100 58.3500 38.2300 41.4300 -12.34%
2018 51.6426 28.3500 80.3500 27.0000 47.2600 68.79%
2017 26.6009 25.9000 33.2000 22.5000 28.0000 10.24%
2016 23.6679 18.9900 30.4200 17.6200 25.4000 25.31%
2015 23.3890 22.1100 27.2600 20.1800 20.2700 -8.28%
2014 21.7201 24.2600 25.7900 18.1200 22.1000 -9.39%
2013 23.7374 23.2100 27.5500 19.7400 24.3900 9.08%
2012 16.9313 14.5200 22.3600 13.6900 22.3600 52.52%
2011 11.9297 11.8300 15.4000 8.8600 14.6600 23.50%
2010 15.7546 23.0000 23.0000 8.3300 11.8700 -47.62%
2009 22.2163 25.9900 30.6900 16.0100 22.6600 -10.33%
2008 38.5238 54.2800 54.2800 19.7000 25.2700 -53.44%
2007 43.4585 32.0500 56.7400 31.1100 54.2700 74.39%
2006 35.4589 37.3700 40.2200 31.1000 31.1200 -15.87%
2005 37.1368 31.5500 46.1300 28.0800 36.9900 13.78%
2004 23.8372 24.0800 32.9000 18.6000 32.5100 36.94%
2003 30.2065 29.4900 41.0500 20.1000 23.7400 -17.22%
2002 33.1802 35.8000 46.5000 19.9500 28.6800 -21.34%
2001 41.7589 31.5000 59.3700 23.2500 36.4600 -0.95%
2000 19.2425 15.2500 36.8100 10.0000 36.8100 145.40%
1999 7.7664 6.8750 16.0000 4.9375 15.0000 93.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.645B $0.100B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $175.389B 32.91
Medtronic (MDT) Ireland $135.096B 21.94
Stryker (SYK) United States $70.813B 27.46
Boston Scientific (BSX) United States $56.240B 32.49
Lonza Group Ag (LZAGY) Switzerland $44.026B 0.00
Baxter (BAX) United States $41.987B 25.68
Terumo (TRUMY) Japan $29.409B 37.59
Zimmer Biomet Holdings (ZBH) United States $28.616B 23.75
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
ResMed (RMD) United States $25.025B 36.34
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $14.731B 66.62
Insulet (PODD) United States $13.054B 552.33
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.631B 51.02
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.229B 12.40
Hill-Rom Holdings (HRC) United States $6.398B 15.88
Canopy Growth (CGC) Canada $6.287B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.378B 0.00
Neogen (NEOG) United States $4.135B 69.09
Haemonetics (HAE) United States $4.050B 26.99
ICU Medical (ICUI) United States $4.048B 30.88
Envista Holdings (NVST) United States $3.688B 25.15
Abcam (ABCZY) $3.604B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.409B 0.00
National Vision Holdings (EYE) United States $2.831B 440.00
Agios Pharmaceuticals (AGIO) United States $2.792B 0.00
NuVasive (NUVA) United States $2.755B 38.40
DFB Healthcare Acquisitions (AHCO) United States $2.045B 188.38
TG Therapeutics (TGTX) United States $2.036B 0.00
AtriCure (ATRC) United States $1.843B 0.00
MacroGenics (MGNX) United States $1.447B 0.00
NanoString Technologies (NSTG) United States $1.356B 0.00
Aphria (APHA) Canada $1.281B 0.00
Aurora Cannabis (ACB) Canada $1.157B 0.00
Cerus (CERS) United States $1.138B 0.00
Cardiovascular Systems (CSII) United States $1.096B 0.00
InMode (INMD) Israel $0.995B 25.10
OraSure Technologies (OSUR) United States $0.960B 0.00
Quanterix (QTRX) United States $0.950B 0.00
Owens & Minor (OMI) United States $0.945B 21.17
Lantheus Holdings (LNTH) United States $0.914B 12.67
Omeros (OMER) United States $0.866B 0.00
PetIQ (PETQ) United States $0.832B 24.04
Phibro Animal Health (PAHC) United States $0.790B 15.76
Meridian Bioscience (VIVO) United States $0.750B 17.32
Vapotherm (VAPO) United States $0.742B 0.00
VAREX IMAGING (VREX) United States $0.637B 15.81
BioLife Solutions (BLFS) United States $0.634B 330.33
Zynex (ZYXI) United States $0.623B 54.39
Eagle Pharmaceuticals (EGRX) United States $0.587B 82.92
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Cytosorbents (CTSO) United States $0.401B 0.00
Viemed Healthcare (VMD) United States $0.399B 14.25
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.327B 0.00
Utah Medical Products (UTMD) $0.300B 25.71
InfuSystems Holdings (INFU) United States $0.258B 143.11
Organigram Holdings (OGI) Canada $0.234B 0.00
Female Health (VERU) United States $0.207B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Exagen (XGN) United States $0.181B 0.00
Bovie Medical (APYX) United States $0.178B 0.00
Fonar (FONR) United States $0.171B 15.14
Surface Oncology (SURF) United States $0.168B 0.00
Wound Management Technologies (SMTI) United States $0.167B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Evolus (EOLS) United States $0.126B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
Capricor Therapeutics (CAPR) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
United-Guardian (UG) United States $0.073B 16.35
Nephros (NEPH) United States $0.071B 0.00
Brainsway (BWAY) Israel $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00